Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm.
about
MYC Deregulation in Primary Human Cancers.Laboratory Investigation of Myeloproliferative Neoplasms (MPNs): Recommendations of the Canadian Mpn Group.ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia.Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis.Mutations in myeloproliferative neoplasms - their significance and clinical use.
P2860
Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm.
@ast
Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm.
@en
type
label
Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm.
@ast
Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm.
@en
prefLabel
Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm.
@ast
Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm.
@en
P2093
P2860
P356
P1476
Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm
@en
P2093
Abdulaziz Hassan
Ahmadu Aliyu Babadoko
Aisha Indo Mamman
P2860
P356
10.4103/0300-1652.149177
P577
2015-01-01T00:00:00Z